- Location
Venous Leg Ulcers
"-
Tactile Medical Has Launched ACTitouch Adaptive Compression Therapy System
Sep 9, 2013Tactile Medical, a US-based provider of home therapy devices, has launched ACTitouch adaptive compression therapy system, an ambulatory device for patients with chronic wounds. The ACTitouch system includes a therapy tracker, wrap-around ...
Tags: Tactile Medical, Venous Leg Ulcers
-
New Dressing for Difficult-to-Heal Wounds Is Launched by Eo2 Concepts
Feb 26, 2013Advanced wound care technology company EO2 Concepts has introduced a new dressing for the treatment of difficult-to-heal wounds. Designed to complement and enhance the company's TransCu O2 tissue oxygenation system, OxySpurOxygen ...
-
ULURU Has Introduced Altrazeal in a 0.75gm Blister Pack Targeting US Chronic Wound Market
Jan 17, 2013Specialty pharmaceutical company ULURU has introduced Altrazeal in a 0.75gm blister pack targeting US chronic wound market. New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and ...
Tags: ULURU, blister pack, pharmaceutical company
-
New Office Is Opened by Convatec in Bangalore,India
Dec 18, 2012ConvaTec, a developer of new medical technologies, has inaugurated a new office at the World Trade Center in Bangalore, India. The new facility, which will serve as headquarters for the company's Indian operations, will offer hospitals ...
Tags: medical technologies, medical, Convatec, healthcare, New Office
-
ULURU Has Completed The Initial Production of The Altrazeal 0.75g Transparent Blister Pack
Dec 6, 2012Pharmaceutical company in the US, ULURU has completed the initial production of the Altrazeal 0.75g transparent blister pack. The Altrazeal 0.75g blister pack, which completed test marketing in the US and Europe, incorporates an ...
Tags: ULURU, CEO, smaller chronic wounds
-
Altrazeal Has Been Received by Its Marketing Partner in Australia
Nov 28, 2012Uluru said that the first shipment of Altrazeal has been received by its marketing partner in Australia. Altrazeal, a wound treatment technology, has shown clinical and economic advantages in a number of chronic and acute wounds, which ...
Tags: Altrazeal, wound treatment technology, marketing partner
-
Avita Starts Recell Spray-on Skin Device Trial in Europe
Nov 27, 2012Avita Medical has initiated an European clinical study of its ReCell Spray-On Skin device, designed for treating venous leg ulcers. Designed for use in burns, plastic, reconstructive and cosmetic procedures, the device uses the company's ...
